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Abstract 
The physical activity recommendation for U.S. adults is to engage in moderate-intensity 
exercise for at least 150 minutes per week. Pedometers have gained popularity as a tool 
for motivating and estimating daily physical activity. Recently it was suggested 3000 
steps in 30 minutes may be equivalent to moderate-intensity walking. To date, this 
recommendation has yet to be examined over an extended period of time. PURPOSE: To 
evaluate changes in cardiorespiratory fitness, body composition, blood lipids, blood 
glucose, and CRP from 150 minutes of free living weekly exercise compared to 
pedometer measured 3000 steps in 30 minutes, five days per week. METHODS: 
Subjects were randomly divided into two interventions (free living and pedometer) for 12 
weeks. A free living (FL) group (n=12) accumulated 150 minutes moderate-intensity 
physical activity per week. A pedometer (P) group (n=13) attended three 30-min 
supervised walking sessions and walked two 30-min sessions independently. Metabolic 
variables were measured pre- and post-intervention. RESULTS: Twenty-five subjects 
began the study and nineteen FL (n=8) and P (n=11) subjects completed the study. 
Adherence was 77.9% and 85.2% in FL and P groups, respectively. SBP (-8.24 ± 11.3; 
p<0.05) and glucose (-7.2 ±11.8mg/dl; p<0.05) were significantly lower in P pre/post. 
Mean changes in CRP (-1.6 mg/dl, p = 0.11), LM (0.14 kg, p = 0.19), and VO2max (1.6 
mg/kg/min, p = 0.2) approached significance in P only. In contrast, FL pre/post 
measurements did not significantly differ in any parameter. HR, BP, GLU, LM, and 
BMD improved in both groups. CRP and VO2max improved in P only. CONCLUSION: 
Evidence suggests the general recommendation of 150 minutes per week does not 
successfully improve metabolic variables or promote adherence. Additionally, there is a 
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dose response to 3000 steps in 30 minutes on metabolic variables compared with 150 
minutes per week. This gives a practical application for the use of pedometers and 
metronomes to monitor intensity and motivate adherence. Further, results indicate 
walking 3000 steps in 30 minutes is an appropriate proxy for meeting the 150 minutes per 
week recommendation.
Chapter One 
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Introduction 
The obesity epidemic has prompted researchers (Chan, Ryan, & Tudor-Locke, 
2004; Coleman et al., 1999) and agencies (Haskell, Lee, Pate, Powell, & Blaire, 2007) to 
recommend modes of exercise that are familiar and easily incorporated into daily routine. 
It is suggested U.S. adults engage in moderate-intensity physical activity for at least 150 
minutes per week. This is equivalent to 30 minutes per day, five days per week (Haskell 
et al., 2007).  More than 50 percent of Americans do not engage in adequate physical 
activity, and about one quarter does not participate in any leisure time physical activity 
(Garrett, Brasure, Schmitz, Schultz, & Huber, 2004). Achieving the recommended 
amount of exercise is related to reduced chronic conditions such as coronary artery 
disease (CAD), hypertension, stroke, insulin sensitivity, osteoporosis, and depression 
(Alevizos, Lentzas, Kokkoris, Mariolis, & Korantzopoulos, 2005; Miller, Balady, & 
Fletcher, 1997). Additionally, the surging cost of health care due to the lack of healthy 
lifestyle has become a serious public health concern (Garrett et al., 2004). Evidence 
suggests there is a need to increase physical activity which can be achieved through 
external devices. Health professionals use various tools to measure exercise intensity 
such as heart rate monitors, pedometers, or rating of perceived exertion (RPE). With 
proper knowledge, these tools may be used as a motivator for exercise.  
Individuals who lack exercise experience may find it confusing to calculate heart 
rate range or determine RPE. Additionally, heart rate monitors are associated with a high 
cost. Conversely, pedometers have gained popularity as a relatively inexpensive and user 
friendly tool for motivating and estimating daily physical activity. They are small tools 
that are worn at the hip and designed to count the number of steps taken per day (Craig, 
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Tudor-Locke, & Bauman, 2006). The current step recommendation is to accumulate 
10,000 steps per day (Hanto, 1993) without specific recommendations for intensity 
(Tudor-Locke & Bassett, 2004). One study reported that this recommendation 
encouraged weight loss and showed improvements in lipid profiles and blood pressure 
(Schneider, Bassett, Thompson, Pronk, & Bielak, 2006). Another study showed that 73% 
of participants who obtained a minimum of 30 minutes of moderate- intensity activity 
also accumulated 10,000 steps in the same day (Welk et al., 2000). Evidence suggests 
that step goals increase physical activity but may be overwhelming for some individuals 
(Tudor-Locke & Bassett, 2004) and does not integrate activity intensity (Marshall et al., 
2009).  
Exercise frequency and duration is easily measured but evidence suggests many 
individuals are unable to gauge what moderate-intensity exercise should feel like when 
they hear or read about it (Rice, Heesch, Dinger, & Fields, 2008). It seems the use of 
pedometers to monitor the steps taken in 30 minutes could be a widely accepted tool for 
obtaining 30 minutes of moderate-intensity exercise (Marshall et al., 2009). Two studies 
used indirect calorimetry to validate step rate associated with moderate-intensity walking 
(Marshall et al, 2009; Tudor-Locke, Colova, Lee, & Swan, 2005). Step count per minute 
was determined by walking at three metabolic equivalents (METSs). These studies 
suggested 100 steps per minute are equivalent to moderate-intensity activity. In order to 
adhere to the guideline, individuals should engage in 3000-4000 steps in 30 minutes, five 
days per week (Marshall et al., 2009).  
 
 
4 
 
 
 
Statement of the Problem 
It is unknown whether 3000 steps in 30 minutes, five days per week is a useful 
proxy for improving metabolic variables. Step count per minute is a less precise 
alternative to measuring METs but could be a helpful health promotion recommendation. 
Additionally, these studies were conducted on a treadmill under controlled conditions 
which reduces their practical validity (Marshall et al., 2009; Tudor-Locke et al., 2005). 
Therefore, the purpose of the proposed study is to evaluate if 150 minutes of free living 
weekly exercise compared to the utility of pedometers to measure 3000 steps in 30 
minutes, five days a week will improve cardiorespiratory fitness, body composition, lipid 
profile, and c-reactive protein (CRP) in sedentary adults. 
Null Hypothesis 
It is hypothesized that walking a minimum of 3000 steps in 30 minutes five days 
per week will not significantly improve blood pressure, body weight, cardiorespiratory 
fitness, body composition, bone mineral density, lipid profile, serum blood glucose, and 
c-reactive protein in sedentary adults. 
Assumptions 
The assumptions for this study are: 
1. The physical activity guidelines set forth by the Center for Disease Control (CDC) 
and American College of Sports Medicine (ACSM) are an accurate standard to 
classify sedentary behavior. 
2. Participants are realistic in their self-assessment of their physical activity 
behaviors and correctly categorized themselves as sedentary. 
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3. Subjects will follow pre-exercise protocols including; avoid exercise, caffeine, 
and any food and liquid consumption 12 prior to testing. 
4. Subjects are realistic about their eating habits and accurately record their diet for 
three days. 
5. Subjects accurately record their physical activity time and steps during 
independent exercise. 
Delimitations 
The delimitations of the study were: 
1. Subjects are limited to a sedentary adult population from the James Madison 
University and Harrisonburg, Virginia communities.   
2. Participants used New Lifestyles Digi-Walker SW-401 pedometers.  
3. A standardized pace of 55 beats per minute as set by a metronome were used during 
supervised walking sessions 
Limitations 
The limitations of the study are: 
1. Subjects are a sedentary population 
2. CDC/ACSM Physical Activity Guidelines are used to determine physical activity 
level  
3. Subjects are non-smokers and apparently healthy and able to complete a walking 
treadmill maximal test were included in the study 
Significance of the Study 
 This is the first known study to evaluate the effect of 3000 steps in 30 minutes on 
metabolic variables including; body weight, body composition, bone mineral density, 
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lipid profile, serum glucose, and maximal exercise capacity. Two previous studies used 
indirect calorimetry to validate step rate associated with moderate-intensity walking 
(Marshall et al, 2009; Tudor-Locke et al., 2005). From these studies, it was recommended 
individuals engage in 3000-4000 steps in 30 minutes, five days per week (Marshall et al., 
2009, Tudor-Locke et al., 2005). Additionally, these studies were conducted on a 
treadmill under controlled conditions which reduces their practical validity (Marshall et 
al., 2009; Tudor-Locke et al., 2005). It is unknown whether these guidelines are useful in 
improving physiological indices after twelve weeks. 
 
Definition of Terms 
Dual-energy x-ray absorptiometry (DXA): Uses low-level radiation and is used to 
assess total bone mineral and estimates bone, fat, and lean tissues. DXA uses x-ray to 
measure whole body or segments at certain places on the body (ACSM, 2006).   
Maximal Oxygen Uptake (VO2max): Used as a measure of cardiorespiratory fitness and 
defined as the highest amount of oxygen that can be transported and used to achieve a 
maximal physical work (ACSM, 2006). 
Rating of Perceived Exertion (RPE): A subjective rating based on general fatigue for 
exercise intensity (ACSM, 2006).  Typically, these ratings correspond to heart rate and 
can be used to determine how the subject is feeling during a maximal exercise test. 
C-Reactive Protein (CRP): CRP is a protein released from the liver in response to 
inflammation.  A high sensitivity C-reactive protein (hsCRP) test can measure the blood 
level of CRP and may predict coronary events. These levels increase in smokers, obese, 
physically inactive individuals, and diabetics (ACSM, 2006).
Chapter Two
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Literature Review 
Introduction 
It is suggested U.S. adults engage in moderate-intensity physical activity for at 
least 150 minutes per week. This is equivalent to 30 minutes per day, five days per week 
(Haskell et al., 2007).  Pedometers have gained popularity as a tool for motivating and 
estimating daily physical activity (Craig et al., 2006). Evidence suggests that step goals 
increase physical activity but may be overwhelming for some individuals (Tudor-Locke 
& Bassett, 2004) and does not integrate activity intensity (Marshall et al., 2009).  
It seems the use of pedometers to monitor the steps taken in 30 minutes could be a 
widely accepted tool for obtaining 30 minutes of moderate-intensity exercise (Marshall et 
al., 2009). Two studies used indirect calorimetry to validate step rate associated with 
moderate-intensity walking (Marshall et al, 2009; Miller et al., 1997). These studies 
suggested 100 steps per minute or 3000-4000 steps in 30 minutes, five days per week 
(Marshall et al., 2009). It is unknown whether these findings are useful for improving 
metabolic variables. Therefore, the purpose this study is to determine if 3000 steps in 30 
minutes is sufficient in improving metabolic variables compared to 150 minutes of free 
living weekly exercise. Metabolic variables will be measured to evaluate if this 
recommendation will improve blood pressure, lipid profile, serum glucose, serum c-
reactive protein, cardiorespiratory fitness, body composition in sedentary adults. 
Metabolic Effects of Exercise 
The following studies report on the metabolic benefits of exercise. One study 
found significant decreases in the sum of skinfolds, waist and hip circumferences, 
diastolic blood pressure(DBP), total cholesterol (TC), triglyceride concentrations and a 
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significant increase in high density lipoprotein cholesterol (HDL) (p< 0.05) in a 6 week 
intervention in middle aged adults. They accumulated 30 minutes, five days per week. 
One group exercised for 30 minutes, five days a week and the other exercised for three 
10-minute bouts. Both groups showed significant improvements in the aforementioned 
physiological variables (Murphy, Nevill, Nevill, Biddle, & Hardman, 2002). Another 
study found similar response to blood pressure (BP) in newly diagnosed hypertension 
patients. Subjects participated in a six month intervention walking an extra 30 minutes 
per day using a pedometer to measure steps. While, systolic blood pressure (SBP) 
decreased by 9% and 2.3% in the  intervention and control groups, DBP decreased by 
7.4% in the intervention group only (Sohn, Hasnain, & Sinacore, 2007). Colemen and et 
al. (1999) reported increased cardiorespiratory fitness (VO2max) and decreased DBP after 
a 16-week supervised intervention. Subjects were assigned to one of three groups and 
walked 30 minutes, six days per week. The first group walked 30 continuous minutes, the 
second group walked three 10-minute bouts, and the third group had the choice to walk in 
any combination of bouts as long as each bout was at least five minutes for 30 minutes. 
Fitness levels were measured using a YMCA submaximal cycle ergometer test. After 16-
weeks, VO2max improved from by 2.7, 2.1, and 2.1 ml/kg/min and DBP decreased by 3.4, 
1.3, 0.9 mmHg in the three groups respectively. At the 32 week follow-up, VO2max 
improve by ~5 ml/kg/min, DBP decreased by ~5 mmHg, and SBP ~7 mmHg in all 
groups. Body fat percentage showed significant improvements (p = 0.03) of 0.7, 0.8, and 
0.2% in the 30 minute, 10-minute bouts, and choice group (Coleman et al., 1999).   
Data was obtained from the National Health and Nutrition Examination Survey III 
from 13,748 male and female adults on the effect of exercise on c-reactive protein (CRP). 
10 
 
 
 
Responses from the survey reported leisure- time physical activity including the 
frequency of participation in walking, jogging or running, bicycling outside or on a 
stationary bicycle, swimming, aerobics or aerobic dancing, other dancing, calisthenics, 
gardening or yard work, and lifting weights. Percentage of participants who had elevated 
CRP concentration were 21%, 17%, 13%, and 8% for those who participated in none, 
light, moderate, and vigorous physical activity respectively. The odds ratio for having 
elevated CRP  concentration was 0.98 (95% CI = 0.78-1.23), 0.85 (0.70-1.02), and 0.53 
(0.40-0.71) when age, sex, ethnicity, education, work status, smoking status, cotinine 
concentration (a metabolite in nicotine), hypertension, body mass index (BMI), waist-to-
hip ratio (WHR), HDL, and aspirin use were adjusted for.  When adjusted for age, the 
odds ratio for having elevated CRP was 0.78 (95% CI = 0.64-0.96), 0.59 (0.49-0.70), and 
0.30 (0.22-0.41) in lightly active, moderately active, and vigorously active participants 
compared to sedentary participants.  Evidence suggests leisure time physical activity is 
inversely related to CRP concentration in a dose-response fashion (Ford, 2002). 
Conversely, Zoppini et al. (2006) reported that moderate-intensity exercise twice a week 
did not reduce plasma biomarkers of inflammation and endothelial function in type II 
diabetic patients. CRP and soluble tumour necrosis factor (TNF)-α receptor (a cytokine 
involved in systemic inflammation) also did not change.  There was an increase in HDL. 
Additionally, HbA1C (the average blood glucose concentration over two to three months), 
triglycerides, LDL, body weight, and waist circumference decreased but there was no 
change in BP (Zoppini et al., 2006). In order to see metabolic benefits, the evidence 
suggests 30 minutes of exercise greater than two days per week. 
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Exercise Intensity and Volume 
The following studies evaluate the metabolic effect of both moderate and 
vigorous intensity exercise. O'Donovan et al. (2005) reported high-intensity exercise 
elicited greater improvements in lipid profiles during a supervised exercise sessions in 
previously sedentary men. Both groups exercised three days a week for 24 weeks and 
expended 400-kcal per session. The moderate-intensity group exercised at 60% of VO2max 
and the high-intensity group exercised at 80% of VO2max. Assuming an energy cost of 5 
kcal/l of oxygen, energy expenditure was determined from VO2. An example from the 
author explained that an individual with a VO2max of 3.0 l/min uses 9.0 kcal/min when 
exercising at 60% of VO2max and will expend 400 kcal in 44.4 minutes (400/9). Both 
groups showed improvement in TC, LDL, and HDL but the high-intensity group showed 
significant improvements in TC and LDL. The moderate- intensity group improved TC, 
LDL, and HDL by -0.19, -0.17, and 0.1 mmol/l and the high-intensity group improved 
each by -0.54, -0.52, and 0.01 mmol/l (O’Donovan et al., 2005). Further, two studies 
showed a greater reduction in body fat percentage after 16 weeks (Tremblay, Simoneau, 
& Bouchard, 1994) and 15 weeks (Irving et al., 2008) of high-intensity exercise. Irving et 
al. (2008) reported a significant reduction in abdominal fat from high-intensity exercise 
only and significant improvements in cardiorespiratory fitness in both low-intensity and 
high-intensity exercise. The low-intensity group exercised at or below their lactate 
threshold (RPE 10-12) and the high-intensity group exercised midway between lactate 
threshold and VO2peak (RPE 15-17) three days a week, and at or below their lactate 
threshold (RPE 10-12) two days a week. Abdominal fat circumference decreased from 
683 cm
2
 to 625 cm
2
 (p< 0.001) after 16 weeks of high-intensity exercise training. Low-
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intensity exercise elicited a 1.8 ml/kg/min improvement and high-intensity exercise 
improved by 3 ml/kg/min in cardiorespiratory fitness (Irving et al., 2008). Trembley et al. 
(1994) had an endurance training (ET) group that progressed to 85% of heart rate reserve 
(HHR) for 45 minutes, five days a week and a high-intensity intermittent-training (HIIT) 
group progressed to 19 short- and 16 long- interval sessions of 15 bouts of 30 second 
(60% HHR) and five bouts of 90 second (70% HHR) intervals (Tremblay et al., 1994). 
The ET group exercised for 20 weeks and the HIIT group exercised for 15 weeks. 
Significant decreases in suprailliac skinfold and the sum of three trunk skinfolds 
(subscapular, suprailliac, and abdomen) was found in both programs. Sum of trunk 
skinfold measurements reduced by 6.3mm (p<0.05) after endurance training and 8.7mm 
(p<0.01) after the HIIT program (Tremblay et al., 1994). Davis et al. (2008) reported on 
the acute effects of exercise after both low (50% HRmax) and high-intensity (70% HRmax) 
exercise in 12 postmenopausal women. Blood samples were taken immediately pre- and 
post-exercise, one hour, and 24 hours post- exercise. From pre- to 24-hours post exercise, 
serum triglycerides concentration significantly decreased from 1.3 to 1.2 mmol/l at both 
walking intensities (Davis et al., 2008). 
Evidence from another study reported that volume and not intensity showed 
greater improvements in insulin sensitivity in 154 overweight or obese male and female 
subjects. There were three training groups; low volume-high intensity (115 min/wk), low 
volume-moderate intensity (170 min/wk), and high volume-high intensity (170 min/wk). 
Results showed ~40%, ~90%, ~80% relative change in insulin sensitivity index in each 
group respectively. All groups showed improvements in insulin sensitivity after six 
months but the groups that exercised 170 min/wk had more substantial improvements 
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(Houmard et al., 2003). This is concurrent with American College of Sports Medicine 
and American Heart Association (ACSM/AHA) physical activity and public health 
recommendation of 150 minutes of exercise per week by (Haskell et al., 2007). Greater 
adherence was observed in subjects who walked three days a week verses five days a 
week in a 24-week free-living study. Subjects were randomly assigned to either a control 
or one of two treatment groups. Lipid profile, BMI, WHR, and skinfolds improved in 
both groups but a greater reduction was reported in the 3-day per week group, who also 
had greater exercise volume. The 5-day walk group showed improvement in weight, 
WHR, BMI, and HDL from baseline to 12-weeks. From baseline to 24-weeks they gained 
an average of 3 lbs, increased their LDL, by 6 mg/dl, decreased their HDL by 4 mg/dl, 
and increased their cholesterol by 3 mg/dl. The dropout rate in the 5-day walk group was 
12%. All members in the 3-day walk group completed the study. The 5-day group 
became increasingly non-adherent after the 12-weeks.  The 3-day per week group walked 
an average of 88 minutes per week and the 5-day per week group walked an average of 
85 minute per week. The 3-day walk group lost an average of 2.3 lbs, decreased LDL by 
11 mg/dl, increased HDL by 3 mg/dl, and decreased total cholesterol by 9 mg/dl (Keller 
& Trevinao, 2001).  
A cohort of 73,473 postmenopausal women with cardiovascular disease or cancer 
participated in the Women’s Health Initiative Observational Study.  These women had 
less cardiovascular events from both moderate and vigorous exercise. There was no 
difference in health parameters from walking verses vigorous exercise (Manson et al., 
2002). Another study also found reduced risk in coronary heart disease (CHD) from 
moderate (4-6 METS) and vigorous (6-12 METS) exercise. Additionally, a brisk walking 
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pace for 30 minutes per day was associated with an 18% reduction in CHD risk  
(Tanasescu, Rimm, Willett, Stampfer, & Hu, 2002). Both authors suggest high intensity 
exercise if tolerable but a reduced CHD risk is achieved through moderate-intensity 
exercise (Manson et al., 2002; Tanasescu et al., 2002).  
Pedometers 
Pedometers are useful tools in motivating daily physical activity. Results from a 
survey showed that those who owned a pedometer walked more. They reported that 
ownership was related to inexpensive cost and ease of use (Craig et al., 2006). The 
current step recommendation is to accumulate 10,000 steps per day (Hanto, 1993; 
Schneider et al., 2006, Tudor-Locke, Hatano, Pangarzi, Kang, 2008; Welk et al., 2000). 
According to one study, those who wear a pedometer walk an average of 11,603 steps per 
day. Additionally, 73% of those participants who obtained a minimum of 30 minutes of 
moderate-intensity activity also accumulated 10,000 steps in the same day (Welk et al., 
2000). One free-living study evaluated the 10,000 step recommendation in 56 overweight 
or obese men and women. Participants were asked to accumulate 10,000 steps per day. 
Thirty-eight participants completed the study and 19 adhered to the recommendation. At 
baseline, steps per day were an average of 5,123 steps, and 9,324 and 9117 steps at 20- 
and 36-weeks. Participants (34 subjects) who completed the study lost 2.4 kg (5.28 lbs), 
HDL increased by 3 mg/dl, body fat percentage decreased by 1.9%, and DBP decreased 
by 2 mmHg. Those who adhered to the goal lost 4.5 kg (9.9 lbs), decreased body fat 
percentage by 3.2%, increased HDL by 4 mg/dl, and decreased DBP by 2 mmHg. It 
should be noted that those who did not adhere still increased baseline steps by 2,500, 
however great health benefits were achieved by accumulating 10,000 steps (Schneider et 
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al., 2006). Another study also showed that women who walked greater than 10,000 steps 
had normal BMI, and lower body fat percentage and WHR. Subjects wore a pedometer 
for 7-days and were asked to maintain their typical work and leisure routines. They were 
categorized as inactive (<6000 steps/day), somewhat active (6000-9000 steps/day), and 
regularly active (≥10,000 steps/day). BMI was 29.3 kg/m2, 25.6 kg/m2, and 23.6 kg/m2 
for those were inactive, somewhat active, and regularly active respectively  (Thompson, 
Rakow, & Perdue, 2004). Dwyer et al (2006) measured steps per day for two days in 609 
female subjects and 517 male subjects. At baseline a questionnaire on physical activity 
and television time was collected. They also measured waist circumference and BMI. 
From the two days, greater steps per day were associated with subjects who had lower 
BMI. Those with a normal BMI (<25 kg/m2) walked an average of 12,400 steps per day 
and those classified as obese (BMI >30 kg/m2) walked an average of 9,000 steps per day. 
Both authors conclude that those with regular activity also had normal BMI (Dwyer et al., 
2007; Thompson et al., 2004). 
A pilot study for The First Step Program showed steps per day were increased 
even when the pedometer was sealed in nine male and female subjects with recently 
diagnosed type II diabetes. They participated in a month long intervention to practice 
exercise with goal setting. They then practiced for a month with limited phone contact 
while wearing a sealed pedometer. Finally, there was a two month follow-up after 
pedometers had been returned and there was no further contact. Steps per day increased 
from ~6,500 to ~9,000 at baseline to follow-up. During supervised sessions (weeks 1-4) 
steps increased to ~10,500 steps per day.  Time spent exercising was 34.3 minutes per 
day during the intervention. Exercise time was 23.6 minutes per day during limited phone 
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contact. During the two month follow up, subjects continued regular exercise (mean = 
22.6 min/d). Weight, WHR, and blood pressure all improved from baseline 
measurements. Waist girth showed a significant decrease of 107.7 to 103.3 cm from 
baseline to follow-up. There was a significant decrease in systolic blood pressure of 
139.3 to 128.8 mmHg and diastolic blood pressure decreased from 86.3 to 80.5 mmHg 
(Tudor-Locke, Wilde, Sidman, & Corbin, 2001). In another study, Chan et al. (2004) 
implemented The First Step Program protocol (4 week adoption phase, 8 week adherence 
phase) and showed that physical activity increased in 106 sedentary subjects. Steps per 
day increased from 7,029 to 10,480 and decreases in BMI, WHR, and resting heart rate 
were reported (Chan et al., 2004).  Pedometer use was sufficient in changing exercise 
behavior (Schneider et al., 2003; Tudor-Locke et al., 2002).  
Validity and Reliability of Pedometers 
The present study will use the New Lifestyles Digi-Walker SW-401 pedometers 
manufactured by Yamax which is shown to be both valid and reliable. All Digi-Walkers 
models have an internal sensor mechanism using a coiled spring-suspended lever arm. 
The following studies discuss the validity and reliability of various pedometers. When 
compared to an accelerometer the Yamax SW-200 (manufactured by Yamax) was the 
most valid compared to Omron HJ-105 and Sportline 330 during 24 hour free-living and 
controlled conditions. The Sportline underestimated steps taken in both conditions. The 
Omron was valid under controlled conditions but not during free living conditions 
(LeMasurier, Lee, & Tudor-Locke, 2004).  
When comparing step count on either an outdoor track or treadmill, the Yamax 
Digi-Walker showed no difference in step count on the track verses the treadmill when 
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worn on the right hip (Welk et al., 2000). When comparing pedometers on the left or 
right hip, the Kenz Lifecorder, New Lifestyles, and Yamax Digi-Walker were the most 
reliable. The Sportline and Omron were the least reliable. These results were measured 
by walking 400 m around an outdoor track (Schneider, Crouter, Lukajic, & Bassett, 
2003).  
One study evaluated step count reliability using the Yamax SW-200 
(manufactured by Yamax) among three different BMI categories: normal (<25 kg/m2), 
overweight (25 – 29.9 kg/m2), and obese (≥30 kg/m2). They walked on a treadmill for 3 
minutes at 54, 67, 80, 94, and 107 m/min. Pedometers were placed on the front, side, and 
back. BMI did not affect step count at any placement. Further, placement on the 
waistband did not significantly affect step count (Swartz, Bassett, Moore, Thompson, & 
Strath, 2003). Another study investigated the validity of 10 pedometers (Yamasa 
Skeletone, Sportline 330 and 345, Omron, Yamax Digiwalker SW-701, Kenz Lifecorder, 
New Lifestyles 2000, Oregon Scientific , Freestyle Pacer Pro (FR), and Walk4Life LS 
2525) at the same aforementioned speeds. Most pedometers underestimated steps at 54 
m/min. Accuracy improved at faster speeds and overestimated at slower speeds (Crouter, 
Schneider, Karabulut, & Bassett, 2003). 
Measuring Intensity with Pedometers 
The current ACSM position stand for physical activity is 30 minutes on five days 
each week or vigorous-intensity aerobic physical activity for 20 minutes on three days 
each week (Haskell et al., 2007). Moderate-intensity exercise is defined as 3 to 6 
metabolic equivalents (METs) which is equivalent to 3 to 4 mph (Haskell et al., 2007). 
The inability to properly identify moderate-intensity exercise was presented by Rice et al. 
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(2008). All participants were shown a mass media description of moderate physical 
activity and half were randomized to practice an accurate walking pace. Those who 
received no practice had significantly less success in walking at a moderate-intensity pace 
for 10 minutes than those who did (Rice et al., 2008). The research suggests the need for 
a tool to measure moderate-intensity exercise. Marshall et al. (2009) suggests 3000 steps 
in 30 minutes could be a useful heuristic to accumulate 30 minutes of moderate-intensity 
exercise. Only two studies have determined steps per minute at a moderate-intensity pace 
(Marshall et al., 2009; Tudor-Locke et al., 2005). Both found about 100 steps per minute 
is moderate-intensity exercise. This is about 3000 steps in 30 minutes or 1,000 steps in 10 
minutes. The authors concluded that METs could not be determined by step count per 
minute but might be a good health promotion recommendation (Marshall et al., 2009). 
Conclusion 
Health professionals continue to find recommendations and tools for motivating 
physical activity. Moderate-intensity exercise five days a week has been determined the 
minimum for health benefits. Physical inactivity leads to several health risk factors such 
as cardiovascular disease, obesity, and type II diabetes. Most individuals are unable to 
demonstrate a moderate-intensity pace if they hear or read about it (Rice et al., 2008) and 
external motivators and goals aid in compliance. 
As reported by Keller and Trevinao (2006) it is difficult for individuals to 
accumulate 30 minutes of exercise 5-days a week. This free-living study showed low 
adherence for those who were asked to walk 5-days a week. Perhaps motivation to 
exercise can be enhanced through the use of external devices. Pedometers are accurate 
and inexpensive devices for measuring physical activity. The current step 
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recommendation of 10,000 steps per day has been reported as difficult to achieve. 
Thompson et al. (2004) reported a 50% dropout rate when participants were asked to 
accumulate 10,000 steps per day. Recent research suggests the use of pedometers to 
measure the amount of steps taken during a specific duration in order to motivate 
intensity and MET level (Marshall et al., 2009). 
It is suggested that adults engage in moderate-intensity physical activity for at 
least 150 minutes per week. In order to achieve this recommendation, recent research 
suggests taking 3000 the steps in 30 minutes (Marshall et al., 2009). This suggestion has 
yet to be implemented over an extended length of time and could be a helpful public 
health recommendation. The evidence is clear; physical activity improves metabolic 
parameters, achieving 30 minutes per day has added benefits, and individuals are 
continually seeking external motivators to help reach their goals. The lack of research on 
this recommendation and the lack of adherence reported by other studies confirm the 
need to determine if 3000 steps in 30 minutes are enough to cause changes in 
physiological responses and motivate exercise.
Chapter Three 
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Methodology and Procedures 
Subject Selection 
Subjects were recruited for this study through mass email to James Madison 
University (JMU) faculty, staff, and students and by word of mouth to the surrounding 
community of Harrisonburg and Rockingham County. Subjects were required to be 
sedentary with a score of less than or equal to 3 on the CDC/ACSM Physical Activity 
Guidelines (Martin, Morrow, Jackson, & Dunn, 2000) (Appendix A). Participants 
completed a medical history which was reviewed by a faculty physician (Appendix B) 
and signed an informed consent (Appendix C). The physician was present in the building 
if the participant was determined to be at a moderate risk level for exercise testing. All 
forms were reviewed and approved by the JMU Institutional Review Board. Twenty-five 
(21 women, 4 men) began the program during April 2010. Testing occurred at baseline 
and after 12 weeks.  
Instrumentation 
Height 
Height was measured without shoes to the nearest 0.5 centimeter with a 
stadiometer (Novel Products Inc, Rockton, IL).  
Weight  
Weight was measured to the nearest 0.1 kg with minimal clothing on a balance 
scale (Sunbeam Products Inc Health-O-Meter, Boca Raton, FL).  
Resting Heart Rate and Blood Pressure  
Resting heart rate (HR) and blood pressure were measured using an automated 
blood pressure monitor (Cosmed Tango, Rome, Italy).  Subjects were asked to take the 
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elevator to the Human Performance Laboratory where they rested five minutes before 
measurements are taken.   
Assays 
Total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein 
(LDL), triglycerides, and glucose, were measured using a blood lipid plus glucose 
cassette in the Cholestech LDX analyzer (Cholestech Corporation, Hayword, CA). C-
reactive protein (CRP) was also be measured by the Cholestech LDX analyzer in a high-
sensitivity c-reactive protein (hs-CRP) cassette. Each lot of Lipid Profile plus Glucose 
cassettes and hs-CRP cassettes were calibrated for high and low serum prior to testing. 
The Cholestech LDX system was calibrated prior to each test day using an optics disk 
check procedure and comparing the results against normal values. Subjects were asked to 
fast for 8-12 hours prior to the test and to report to hydrated to increase blood flow. All 
blood samples were collected via fingerstick. The finger was cleaned with an alcohol 
prep pad and pricked using a Tenderlet lancet. The blood sample was collected using a 
capillary tube. The sample was dropped into a cassette tape and inserted into the 
Cholestech LDX. Values for all assays were recorded in the subject’s file.   
Body Composition and Bone Mineral Density 
Lean mass (LM), fat mass (FM) and bone mineral density (BMD) were measured 
using the Lunar Prodigy Primo dual-energy X-ray absorptiometry (DXA) (GE 
Healthcare, Madison, WI). The DXA was calibrated according to manufacturer’s 
instructions each day before a scan was performed. Subjects were asked to wear 
comfortable clothing and remove any metal prior to the scan. Subjects were placed supine 
on the scan table, with palms facing medially. A Velcro strap was placed around the 
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ankles and thighs to minimize movement. A whole body scan was conducted lasting 
approximately 8-10 minutes each. According to the manufacture’s specifications, one 
DXA scan exposes subjects to 1.5 mrem of radiation. The exposure to radiation during a 
single chest x-ray (i.e., 5 mrem) is more than 3 times greater than radiation from DXA. 
Also, the radiation from one DXA scan is equivalent to 1.5 days of natural background 
radiation in the United States. A full body densitometry and full body composition report 
were printed at the conclusion of the scan.  
Volitional Maximal Exercise Test 
A walking test to volitional exhaustion (VO2max) was performed on a motorized 
treadmill (h/p Cosmos, Cosmed, Rome, Italy). Prior to treadmill testing, subjects were 
oriented to walking on a treadmill with expired air channeled to a metabolic cart. The 
subject warmed-up for three minutes prior to the test at a self selected walking speed less 
than 2.0 miles per hour (mph). The treadmill protocol consisted of a fixed self selected 
walking speed which increased in grade by 2.5% at three minute intervals until volitional 
exhaustion was met. Oxygen uptake was continuously recorded using the Quark b² 
Pulmonary Gas Exchange system (Cosmed, Rome, Italy). Once volitional exhaustion was 
met, the subject cooled down for three minutes. Subjects were required to rest in the 
Human Performance Laboratory until heart rate was below 100 beat per minute. Subjects 
were instructed to refrain from heavy exercise the remainder of the day and avoid a hot 
shower and large meal three hours following the test.   
Three-Day Food Record 
Nutritional intake was measured with a three-day diet analysis. Subjects were 
asked to record two week days and one weekend day (Appendix D). Calorie intake and 
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macronutrient percentage (carbohydrates, fat, and protein) were analyzed using Diet 
Analysis Plus, version 8.0.  
Experimental Design 
 Subjects were randomly assigned to two groups, free living and pedometer. The 
interventions were twelve weeks in duration. The free living group was asked to 
accumulate 150 minutes of exercise and record their time and type of exercise. They were 
given the definition of moderate-intensity exercise; exercise from 3 to 6 METs. Examples 
were given, which included walking (3-4 mph), heavy cleaning (washing windows, 
mopping, vacuuming, etc), bicycling on flat surface or stationary bike, ballroom dancing, 
leisure swimming, recreational basketball, and volleyball (Haskell et al., 2007). The 
pedometer group was given a New Lifestyles Digi-Walking SW 401 pedometer and 
asked to attend three 30 minute supervised walking sessions and walk two 30 minute 
walking sessions independently. The pedometer was worn on the waist in-line with the 
mid-thigh. During the supervised walking sessions, subjects walked to the beat of 
metronome set at 55 beats per minute to ensure a minimum of 3000 steps. Subjects were 
instructed to land on the same foot for each beat. Total steps taken for each session were 
recorded in a log kept by the researcher. All sessions were conducted on the JMU outdoor 
track or JMU University Recreation indoor track. Subjects wore the same pedometer but 
walked without the metronome during independent walks and self-recorded steps taken.  
 Subjects were required to attend an orientation session and two testing sessions at 
the beginning and end of the twelve weeks. Both groups were given logs to record three-
day diet and exercise. Three day diet records were collected at after the first week of 
exercise and exercise logs were collected at the end of the 12 weeks. A second three day 
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food record was given as an email attachment so subjects could record intake during their 
last week of exercise. Subjects increased their exercise from 60 minutes in week one, 90 
minutes in week two, 120 minutes in week three, and 150 minutes weeks four through 
twelve.  
Statistical Analysis 
SPSS 18.0 (student version) was used to analyze responses of physiological 
variables (HR, systolic blood pressure, diastolic blood pressure, TC, LDL, HDL, 
triglycerides, glucose, CRP, FM, LM, BMD, VO2max, calories, and percent carbohydrate, 
protein, and fat) pre and post intervention.  A repeated measures ANOVA was used to 
compare the physiological responses between the free living and pedometer group. A 
paired samples t-test and nonparametric sign test was used to compare change in 
physiological variables from pre and post the intervention. A prior significance was 
established at p < 0.05.
 
 
 
Chapter Four  
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Results 
Subjects 
 The purpose of this study was to determine if walking five days a week at a pace 
of 3000 steps in 30 minutes would elicit an improvement on metabolic variables 
including blood pressure (BP), cardiorespiratory fitness (VO2max), body composition, 
lipid profile, blood glucose, and c-reactive protein (CRP). This recommendation was 
compared to a free living intervention of 150 minutes of a moderate intensity per week.  
Twenty-five participants began the study (12 free living subjects and 13 pedometer 
subjects). Nineteen participants completed the study (8 free living subjects and 11 
pedometer subjects). All participants were sedentary according to the ACSM/CDC 
physical activity guidelines, “I am trying to start to exercise or walk, or I exercise or walk 
infrequently.” Out of the 19 participants who completed the study, 16 were female and 3 
were male. The demographic information can be found in Tables 1 and 2.  
Table 1: Demographic Information (Means ± Standard Deviation) 
Participants  19 (16 female, 3 male) 
Age (yr) 43.98 ± 13.42 
Height (cm) 166.42 ± 6.90 
Weight (kg) 88.22 ± 25.08 
 
Table 2: Demographic Information by Group (Means ± Standard Deviation) 
  Pedometer Free Living 
Participants  11 (8 female, 3 male) 8 (8 female) 
Age (yr) 45.18 ± 13.08 42.13 ± 14.59 
Height (cm) 168.36 ± 8.27 163.59 ± 2.99 
Weight (kg) 86.66 ± 20.32 90.36 ± 31.91 
 
Adherence 
The attrition rate was 33% (12 to 8 subjects) in the free living group versus 15% 
(13 to 11 subjects) in the pedometer group. Free living subjects exercised at a moderate 
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intensity for 150 minutes per week. Average minutes per week were 106.78 ± 22.6. 
Adherence was 77.9%. The pedometer group met with supervised group sessions three 
times per week and walked independently twice a week. Adherence during supervised 
sessions was 79.1% and adherence for independent walking was 91.9%. Total adherence 
for independent and supervised walking was 85.2%. Average steps during supervised 
sessions was 3164.94 ± 302 steps and average steps during independent walking sessions 
was 3230.38 ± 362 steps.  
Physiological Variables 
 In order to measure the metabolic benefits of the walking program, physiological 
data was taken at baseline and 12 weeks. Changes in weight, heart rate (HR), BP, lean 
mass (LM), fat mass (FM), bone mineral density (BMD), blood lipids, blood glucose, c-
reactive protein (CRP), and VO2max were recorded. The difference between groups was 
analyzed using repeated measures ANOVA. Results in LDL showed a statistically 
significant difference between groups (p <0.05). There were no differences between 
groups in any other measurement. The differences between pre and post measurements 
were analyzed using a paired samples t-test and non parametric sign test. The results for 
each group are found in Tables 4 and 5. Systolic blood pressure (SBP) and blood glucose 
was significantly lower in the pedometer group (p<0.05). SBP was found to be significant 
from both the t-test and sign test. Glucose was found to be significant from the sign test 
only. Low density lipoprotein cholesterol (LDL) was significantly higher in free living 
group (p<0.05; t-test). There were no significant differences in other parameters. 
Although not statistically significant, 8 out of 11 subjects improved lean mass (LM) in 
the pedometer group. Additionally, 6 out of 11 subjects showed improvement in CRP but 
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due to the sensitivity of the testing procedure any value <0.3 or >10 mg/dl is not detected. 
One subjected had <0.3 and one subject was >10 mg/dl from baseline to week 12. In the 
free living group 6 out of 8 subjects showed improvements in SBP and HR. HR (Fig. 1), 
SBP (Fig. 2), diastolic blood pressure (DBP) (Fig. 3), high density lipoprotein cholesterol 
(HDL) (Fig. 6), and blood glucose (Fig. 8) decreased in both groups. Total cholesterol 
(TC) (Fig. 4), LDL (Fig. 5), triglycerides (Fig. 7), FM (Fig. 11), LM (Fig. 12), and BMD 
(Fig. 13) increased in both groups. VO2max (Fig. 10) increased in the pedometer group and 
decreased in the free living group. CRP (Fig. 9) decreased in the pedometer group and 
increased in the free living group.  
Power Calculation 
 A power calculation was completed to determine the probability of detecting an 
ideal clinical change for various sample sizes. Results are in Table 3. It is likely that a 
larger sample size would have identified if statistically significant differences would have 
occurred between groups and from pre to post tests. 
Table 3: The Probability of Detecting a Clinical Change for Various Sample 
Sizes 
Number of Subjects  5 10 15 20 25 30 
HR (bpm) 0.26 0.59 0.8 0.91 0.96 0.98 
SBP (mmHg) 0.51 0.91 0.99 0.99 1 1 
DBP (mmHg) 0.08 0.14 0.19 0.24 0.3 0.35 
TC (mg/dL) 0.09 0.16 0.24 0.31 0.38 0.45 
LDL (mg/dL) 0.09 0.17 0.25 0.33 0.4 0.47 
HDL 0.07 0.11 0.16 0.2 0.24 0.28 
Triglycerides (mg/dL) 0.06 0.07 0.09 0.11 0.12 0.14 
Glucose (mg/dL) 0.57 0.94 0.99 1 1 1 
CRP (mg/dL) 0.5 0.9 0.99 0.99 1 1 
FM (kg) 0.17 0.37 0.54 0.68 0.79 0.86 
LM (kg) 0.11 0.22 0.33 0.43 0.52 0.6 
VO2max (ml/kg/min) 0.16 0.35 0.52 0.65 0.76 0.83 
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Table 4: Physiological Responses in Pedometer Group from Baseline to Week 12 
  Baseline Week 12 
Mean 
Change 
(post-pre) 
Std. 
Deviation 
(post-pre) 
Std. Error 
Mean 
(post-pre) 
2-tailed  
significance 
Heart Rate 
(bpm) 76 75 -0.545 11.52 3.48 0.88 
SBP  
(mmHg) 129 121 -8.273 11.3 3.41 0.04* 
DBP  
(mmHg) 77 75 -1.636 9.64 2.91 0.57 
TC 
(mg/dl) 192 198 5.091 19.36 5.84 0.4 
LDL 
(mg/dl) 113.5 113.9 0.333 12.95 4.32 0.94 
HDL 
(mg/dl) 48 46 -1.667 10.15 3.38 0.64 
Trig 
mg/dl 115 133 17.3 32.64 10.32 0.12 
Glucose 
(mg/dl) 104 97 -7.182 11.98 3.61 0.07 
CRP  
(mg/dl) 4.2 2.6 -1.6 2.433 0.86 0.11 
VO2max  
(ml/kg/min) 29.9 31.5 1.6 3.74 1.18 0.21 
Fat Mass  
(kg) 35.9 36 0.1 1.29 0.39 0.72 
Lean Mass 
(kg) 47 47.6 0.6 1.4 0.42 0.19 
BMD  
(g/cm2) 1.259 1.262 0.002 0.0169 0.0051 0.77 
* Statistically significant (p < 0.05) 
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Table 5: Physiological Responses in Free Living Group from Baseline to Week 12 
  Baseline Week 12 
Mean 
Change 
(post-pre) 
Std. 
Deviation 
(post-pre) 
Std. Error 
Mean 
(post-pre) 
2-tailed  
significance 
HR 
(bpm) 71 70 -1.5 2.976 1.052 0.197 
SBP  
(mmHg) 126 119 -6.9 11.051 3.907 0.122 
DBP  
(mmHg) 76 73 -3.1 8.184 2.894 0.316 
TC 
(mg/dl) 175 178 2.5 8.184 4.563 0.6 
LDL 
(mg/dl) 98 110 12 11.81 4.464 0.04* 
HDL 
(mg/dl) 54 47 -7.3 10.525 3.721 0.09 
Trig 
mg/dl 122 127 5 50.73 19.18 0.8 
Glucose 
(mg/dl) 104 102 -1.8 8.102 2.864 0.56 
CRP  
(mg/dl) 4.6 5.2 0.6 2.003 0.818 0.49 
VO2max  
(ml/kg/min) 31.5 30.9 -0.5 4.984 2.035 0.8 
Fat Mass  
(kg) 41.2 41.3 0.08 1.354 0.479 0.89 
Lean Mass 
(kg) 44.9 45.3 0.3 2.185 0.772 0.67 
BMD  
(g/cm2) 1.239 1.254 0.016 0.023 0.008 0.1 
*Statistically significant (p < 0.05)     
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Figure 1: Heart rate between groups from baseline to week 12  
Note: Group and time interaction p= 0.90; Post-pre mean effect p=0.26; 
 Pedometer post-pre p = 0.88; Free Living post-pre p= 0.20 
 
 
 
 
 
 
 
 
 
 
  
Figure 2: Systolic blood pressure between groups from baseline to week 12  
Note: Group and time Interaction p=0.8; Post-pre mean effect p =0.38; 
Pedometer post-pre p=0.04*; Free Living post-pre p =0.12 
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Figure 3: Diastolic blood pressure between groups from baseline to  
week 12  
Note: Group and time interaction p= 0.83; Post-pre mean effect p= 0.73; Pedometer p=0.57;  
Free Living p= 0.32 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Total cholesterol between groups from baseline to week 12  
Note: Group and time interaction p= 0.90; Post-pre mean effect p= 0.81; Pedometer  
p= 0.40; Free Living p= 0.60 
70
71
72
73
74
75
76
77
78
Baseline Week 12
D
B
P
 (
m
m
H
g
)
Pedometer
Free Living
160
165
170
175
180
185
190
195
200
Baseline Week 12
T
C
 (
m
g
/d
l)
Pedometer
Free Living
34 
 
 
 
Figure 5: LDL between groups from baseline to week 12 showed a significant 
interaction  
Note: Group and time interaction p<0.05; Post-pre mean effect p= 0.13; Pedometer  
p= 0.94; Free Living p= 0.04* 
 
 
 
 
 
 
 
 
 
 
Figure 6: HDL between groups from baseline to week 12  
Note: Group and time interaction p= 0.32; Post-pre mean effect p= 0.66; Pedometer 
p= 0.64; Free Living p= 0.09 
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Figure 7: Serum triglycerides between groups from baseline to  
week 12  
Note: Group and time interaction p= 0.69; Post-pre mean effect p= 0.59; Pedometer  
p= 0.12; Free Living p= 0.80 
 
 
 
 
Figure 8: Blood glucose between groups from baseline to week 12  
Note: Group and time interaction p= 0.37; Post-pre mean effect p= 0.96; Pedometer p= 0.07:  
Sign p = 0.03; Free Living p= 0.56 
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Figure 9: C-reactive protein between groups from baseline to week 12  
Note: Group and time interaction p= 0.22; Post-pre mean effect p= 0.91; Pedometer p= 0.11 
Free Living p= 0.50 
 
 
 
 
 
 
Figure 10: Maximal oxygen uptake between groups from baseline to  
week 12  
Note: Group and time interaction p= 0.35; Post-pre mean effect p= 0.70; Pedometer p= 0.21; 
Free Living p= 0.80 
0
1
2
3
4
5
6
Baseline Week 12
C
R
P
 (
m
g
/d
L
)
Pedometer
Free Living
29
29.5
30
30.5
31
31.5
32
Baseline Week 12
V
O
2
m
a
x
 (
m
l/
k
g
/m
in
)
Pedometer
Free Living
37 
 
 
 
Figure 11: Fat mass between groups from baseline to week 12  
Note: Group and time interaction p= 0.89; Post-pre mean effect p= 0.08; Pedometer p= 0.72;  
Free Living p= 0.89 
 
 
 
 
 
 
 
Figure 12: Lean mass between groups from baseline to week 12  
Note: Group and time interaction p= 0.66; Post-pre mean effect p= 0.06; Pedometer p= 0.19;  
Free Living p= 0.67 
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Figure 13: Bone mineral density between groups from baseline to  
week 12  
Note: Group and time interaction p= 0.26; Post-pre mean effect p=0.80; Pedometer p=0.77;  
Free Living p=0.10 
 
Three Day Diet Analysis 
 Participants were instructed to record their food and fluid intake for three days 
(two week days, one weekend day) during their first and last week of physical activity.  
Diet logs were analyzed for calories (kcal) and energy nutrients (carbohydrate, fat, and 
protein).  Changes within each group were analyzed using a paired sample t-test.  Table 6 
reports the differences in calories, carbohydrate, fat, and protein consumption for the 
pedometer group only.  There were no significant differences in diet composition at week 
1 and week 12 for the either group.  Mean differences for carbohydrate (CHO), fat 
(FAT), and protein (PRO) consumption are found in Table 6 for pedometer group and 
Tables 7 for free living group.  
 
 
 
 
1.22
1.225
1.23
1.235
1.24
1.245
1.25
1.255
1.26
1.265
1.27
Baseline Week 12
B
M
D
 (
g
/c
m
2
)
Pedometer
Free Living
39 
 
 
 
Table 6: Mean Calorie Intake and Macronutrient Differences in Pedometer Group 
(n=8) 
  
Mean 
Change 
(post-pre) 
Std. Deviation 
(post-pre) 
Std. Error Mean 
(post-pre) 
2-tailed  
significance 
Kilocalories -352.38 739.58 261.48 0.22 
Carbohydrate (%) -3.88 9.64 3.41 0.29 
Protein (%) 1.5 2.62 0.93 0.15 
Fat (%) 2.75 7.48 2.64 0.33 
 
Table 7: Mean Calorie Intake and Macronutrient Differences in Free Living Group 
(n=7) 
  
Mean 
Change 
(post-pre) 
Std. Deviation 
(post-pre) 
Std. Error Mean 
(post-pre) 
2-tailed  
significance 
Kilocalories -19.43 434.89 164.37 0.91 
Carbohydrate (%) -0.57 7.14 2.7 0.84 
Protein (%) 1.86 4.81 1.82 0.35 
Fat (%) -2.43 6.83 2.58 0.38 
 
 
 
Figure 14: Calorie intake between groups from baseline to week 12  
Note: Group and time interaction p= 0.23; Post-pre mean effect p=0.34; Pedometer p=0.22;  
Free Living p=0.91 
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Figure 15: Carbohydrate intake between groups from baseline to week 12  
Note: Group and time interaction p= 0.55; Post-pre mean effect p=0.87; Pedometer p=0.29;  
Free Living p=0.84 
 
 
 
 
 
 
Figure 16: Protein intake between groups from baseline to week 12  
Note: Group and time interaction p= 0.99; Post-pre mean effect p=0.08; Pedometer p=0.15;  
Free Living p=0.35 
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Figure 17: Fat intake between groups from baseline to week 12  
Note: Group and time interaction p= 0.20; Post-pre mean effect p=0.37; Pedometer p=0.33;  
Free Living p=0.38 
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Discussion 
Introduction 
 The purpose of this study was to compare walking 3000 steps in 30 minutes five 
days per week to 150 minutes of moderate-intensity physical activity per week. To date 
this is the first known study to evaluate the dose response of the current recommendation 
of 3000 steps in 30 minutes (Marshall, et al 2009; Tudor-Locke et al, 2005). The results 
of this study will provide practical application of pedometer use to monitor walking 
intensity. Additionally, it applies the potential use of metronomes to maintain step pace, 
and therefore walking intensity, to serve as a suitable proxy for exercise intensity. 
 In order to compare the step recommendation to the 150 minutes per week, 
subjects were randomly assigned to a free living and pedometer group. The free living 
group accumulated 150 minutes of moderate intensity exercise per week. The pedometer 
group attended three supervised groups per week and walked independently twice a 
week. During the supervised sessions, subjects walked to the beat of a metronome set at 
55 beats per minute in order to maintain a minimum of 3000 steps in 30 minutes. They 
were instructed to land on the same foot for each beat. Additionally, a three-day diet 
record was completed during the first and last week of physical activity and subjects were 
asked to keep diet consistent during the entire study. All data was analyzed using 
repeated measures ANOVA to compare metabolic responses of 150 minutes a week 
verses 3000 steps in 30 minutes five days per week. A paired samples t-test and 
nonparametric sign test analyzed the change from baseline to week 12 measurements of 
each group.  
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Adherence 
Overall adherence was 77.9% in the free living group and 85.2% in the pedometer 
group. In the free living group, attrition was 33% (12 to 8 subjects) versus (13 to 11 
subjects) 15% in the pedometer group. Additionally, the free living group became 
progressively non-adherent from week 6 to week 12 (average minutes 147 ± 96 min vs. 
89.62 ± 96 min). One subject reported zero physical activity during the study and another 
subject reported zero physical activity after week 7.  
In the pedometer group, adherence during supervised sessions was 79.1% and 
adherence for independent walking was 91.9%. Four subjects were 100% adherent and 
only two subjects were less than 75% adherent (70% and 57%). None of the participants 
were 100% adherent during supervised sessions but walked extra days on their own when 
they missed a session.  
Keller & Trevinao (2001) reported a dropout rate of 12% when subjects were 
asked to walk 30 minutes, five days a week. This is similar to the attrition rate in the 
pedometer group in this study. Conversely, they reported that subjects became 
progressively non-adherent (Keller & Trevinao, 2001) whereas subjects in this study 
were 85.2% adherent. Motivation to continue exercising may be attributed to supervision. 
A pilot study for The First Step Program showed exercise time increased during 
supervised sessions. Steps increased from 6,500 to approximately 10,500 steps per day 
and time spent exercising was 34.3 minutes per day. When subjects were then asked to 
practice walking on their own, with limited contact, walking time was 23.6 minutes per 
day. During a two month follow up, subjects continued regular exercise (mean = 22.6 
min/d) (Tudor-Locke, 2001). 
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150 Minutes per Week 
The free living group exercised 150 minutes a week at a moderate intensity. The 
American College of Sports Medicine, Centers for Disease Control and Prevention, and 
American Heart Association suggest that adults engage in moderate-intensity physical 
activity for at least 150 minutes per week. Moderate-intensity exercise is defined as 
exercise between 3 to 6 metabolic equivalents (METs) and examples include walking (3-
4 mph), heavy cleaning (washing windows, mopping), bicycling on flat surface, ballroom 
dancing, leisure swimming, and volleyball (Haskell et al., 2007). In the present study, the 
free living group showed no statistically significant improvements in any metabolic 
parameters. Heart rate (HR) (-1.5 bpm, p = 0.19), systolic blood pressure (SBP) (-
6.88mmHg, p = 0.12), diastolic blood pressure (DBP), blood glucose, lean mass (LM), 
and bone mineral density (BMD) improved. All other parameters worsened and low 
density lipoprotein cholesterol (LDL) showed a statistically significant increase (11.86 
mg/dl, p < 0.05). Some of these results may be skewed due to one subject reporting zero 
physical activity during the study and another subject reporting zero physical after week 
7.  
Houmard et al. (2003) reported that volume and not intensity showed greater 
improvements in insulin sensitivity in overweight or obese male and female subjects. The 
study included three training groups; low volume-high intensity (115 min/wk), low 
volume-moderate intensity (170 min/wk), and high volume-high intensity (170 min/wk). 
All groups showed improvements in insulin sensitivity (~40%, ~90%, ~80% relative 
change per group respectively) after six months but the groups that exercised 170 min/wk 
had more substantial improvements (Houmard et al., 2003). Other studies have shown 
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improvements in HR, BP, VO2max, and body composition from 150 minutes of physical 
activity per week but the majority of the evidence is from structured activity such as 30 
minutes, five days a week (Murphy et al, 2002; Sohn et al, 2007; Coleman et al., 1999; 
Ford, 2002). Similar to the evidence reported by Houmard et al., our study showed 
improvements in serum glucose concentration in the free living group but it seems a 
structured program aids in the improvement of other metabolic indices.  
Pedometers & Metronomes: 3000 Steps in 30 Minutes 
Moderate-intensity exercise is defined as 3 to 6 METs which is equivalent to 3 to 
4 mph (Haskell et al., 2007). It is suggested 3000 steps in 30 minutes could be a useful 
recommendation for motivation to accumulate 30 minutes of moderate-intensity exercise. 
Two studies reported that about 100 steps per minute is considered moderate-intensity 
exercise (3 METs). This is equivalent to 3000 steps in 30 minutes or 1,000 steps in 10 
minutes (Tudor-Locke et al., 2005, Marshall et al., 2009). In this study, average steps 
during supervised sessions were 3164.94 ± 302 and 3230.38 ± 362 during independent 
walking sessions. 
Pedometers are useful tools in motivating daily physical activity (Craig et al., 
2006). Results from a survey showed that those who owned a pedometer walked more. 
They reported that ownership was related to inexpensive cost and ease of use (Craig et 
al., 2006). Another study reported that 73% of the participants who obtained a minimum 
of 30 minutes of moderate-intensity activity also accumulated 10,000 steps in the same 
day (Welk et al., 2000), the current step recommendation (Hanto, 1993). This study did 
not measure total steps per day but in addition to group supervised sessions, pedometers 
may have been associated with compliance to the exercise program. Additionally, it 
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seems to be an appropriate tool to measure 3000 steps in 30 minute and elicit a moderate 
intensity walking pace.  
To better adhere to the step recommendation, subjects walked to the beat of a 
metronome three days per week and practiced the pace on their own twice a week. Since 
there was no difference between supervised and independent average steps, participants 
were able to keep the pace on their own. Other studies successfully used metronomes to 
improve gait in newly diagnosed Parkinson’s patients (Howe, Lovgreen, Cody, Ashton, 
Oldham, 2003) or to improve walking speed during a progressive exercise test (Wise & 
Brown, 2005). These results suggest that the addition of metronomes may improve 
walking pace and therefore moderate-intensity exercise.  
Thirty Minutes, Five Days per Week 
In this study, the pedometer group walked for 30 minutes, five days per week. 
SBP (-8.27 mmHg, p< 0.05) and blood glucose (-7.18 mg/dl, p< 0.05) were significantly 
lower from baseline to week 12. Other parameters showed improvements that approached 
significance including c-reactive protein (CRP) (-1.6 mg/dl, p = 0.11), lean mass (LM) 
(0.14 kg, p = 0.19), and VO2max (1.6 mg/kg/min, p = 0.2). Other statistically insignificant 
improvements were seen in HR, DBP, and BMD.  
One study reported significant decreases in the sum of skinfolds, waist and hip 
circumferences, and DBP after a six week intervention of 30 minutes, five days a week 
(Murphy et al., 2002). Sohn et al. (2007) found similar response to blood pressure in 
newly diagnosed hypertension patients after six months of walking 30 minutes per day 
using a pedometer to measure steps. There was a 9% reduction in SBP and DBP 
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decreased by 7.4%. These findings are not statistically significant and can be a result of 
the small sample size (n=8) (Sohn et al., 2007).  
Similar to our study, Coleman et al. (1999) reported increased VO2max and 
decreased DBP after a 16-week supervised intervention. Subjects were assigned to one of 
three groups and walked 30 minutes, six days per week; (1) 30 continuous minutes, (2) 
three 10-min bouts, or (3) the choice of any combination of bouts as long as each bout 
was at least five minutes. VO2max improved from by 2.7, 2.1, and 2.1 ml/kg/min and DBP 
decreased by 3.4, 1.3, 0.9 mmHg in the three groups respectively (Coleman et al., 1999). 
In our study, it seems the dose-response of 3000 steps in 30 minutes is appropriate 
to elicit improvements in CRP. Due to the lack of sensitivity in the testing procedure one 
subject was below 0.3 mg/dl and one subject was above 10 mg/dl at baseline and after the 
pedometer intervention and it is unknown whether there were improvements. Conversely, 
fat mass increased in our study. Total calorie and macronutrient intakes did not 
significantly differ from baseline to week 12 which further ensures physiological 
responses were not attributed to differences in diet.  There are conflicting views on 
whether the decrease in CRP is a result of increased cardiorespiratory fitness (Ford, 2002, 
Hammlett et al., 2006) or decreased fat mass (Tchernof, Nolan, & Sites, 2002). Evidence 
from one study showed leisure time physical activity was inversely related to CRP 
concentration in a dose-response fashion (Ford, 2002). Conversely, Houfman et al (2006) 
reported six months of aerobic exercise training was not resultant of significant change in 
CRP in an at-risk population. One study found no significant decrease in CRP 
concentration after an exercise program where body fat remained unchanged and VO2max 
was improved by 18% (Hammlett et al., 2006). Tchernof et al (2002) reported decreased 
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fat mass was a significant predictor of decreased CRP concentration from calorie-
restricted weight loss in postmenopausal women. Due to the conflicting evidence, further 
research should be completed on the effect of physical activity on plasma CRP 
concentration.  
Conclusion 
 Based on the results of this study, walking 3000 steps in 30 minutes is an 
appropriate recommendation for meeting the 150 minutes per week recommendation. 
These findings confirm the 3000 steps in 30 minutes recommendation made by Marshall 
et al. (2007) and Tudor Locke et al. (2002). In our study, evidence suggests that the 
general recommendation of 150 minutes per week does not successfully improve 
metabolic variables or promote adherence. Adherence may be improved with the use of 
pedometers and metronomes as external motivators and through attending supervised 
groups to meet the 150 minutes per week recommendation.  
Additionally, there is a dose response to 3000 steps in 30 minutes in metabolic 
variables compared with the general recommendation of 150 minutes per week. This 
study agrees with previous findings that 30 minutes of moderate-intensity walking 
improves metabolic variables (Murphy et al, 2002; Sohn et al, 2007; Coleman et al., 
1999; Ford, 2002). Our study adds to the body of research by giving a practical 
application for the use of pedometers and metronomes to monitor intensity and motivate 
adherence.  
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Conclusions 
1. Unsupervised moderate-intensity exercise 150 minutes a week showed statistically 
insignificant improvements in HR, BP, blood glucose, LM, and BMD. All other variables 
worsened. 
2. There are statistically significant improvements in SBP and serum blood glucose and 
CRP, LM, and VO2max approached significance  from walking 3000 steps in 30 minutes, 
five days per week. 
3. There is a dose response to 3000 steps in 30 minutes to improve metabolic variables 
compared to the general recommendation of 150 minutes per week.  
4. Walking 3000 steps in 30 minutes is an appropriate proxy for meeting 150 minutes of 
moderate-intensity exercise per week.  
5. The use of pedometers and metronomes promote adherence to the goal of 3000 steps in 
30 minutes 
6. Supervised sessions to practice the use of pedometers improves adherence to the goal 
of 3000 steps in 30 minutes. 
Recommendations 
1. Some metabolic variables approached significance, which suggests that a study with a 
larger sample size and more adherences to the walking goals may produce more 
significant results after the 12 weeks of walking 
2. A study longer in duration may also show significant improvements in metabolic 
variables.  
3. Evaluating either a male or female only population would control the outcome of the 
study and differences in physiological measures that could be related to gender. 
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4. Further research should evaluate the use of metronomes as an external motivator on 
independent walking 
5. In this study subjects walked on a flat surface, future studies should evaluate the use of 
metronomes to keep pace on a varied terrain 
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Appendix A 
CDC/ACSM Physical Activity Guidelines 
 
1. I do not exercise or walk regularly now, and do not intend to start in the near future. 
 
2. I do not exercise or walk regularly, but I have been thinking of starting. 
 
3. I am trying to start to exercise or walk, or I exercise or walk infrequently. 
 
4. I am doing vigorous exercise less than 3 times per week or moderate physical activity less than 
5 times per week. 
 
5. I have been doing moderate physical activity 5 or more times per week (or than 2 ½ hours per 
week) for the last 1-6 months. 
 
6. I have been doing moderate physical activity 5 or more times per week (or more than 2 ½ 
hours per week) for 7 months or more. 
 
7. I have been doing vigorous exercise 3 to 5 times per week for 1-6 months. 
 
8. I have been doing vigorous exercise 3 to 5 times per week for 7 months or more. 
 
 
Moderate Physical Activity: brisk walking, gardening, slow cycling, dancing, or hard work 
around the house 
 
Vigorous Physical Activity: basketball, jogging, running fast, step aerobics, swimming laps, or 
singles tennis. 
 
 
 
Print Name: ______________________________ 
 
Signature:   _______________________________  Date: _____________ 
 
Witness: _________________________________  Date: _____________ 
 
 
Martin, S., Morrow, J., Jackson, A., & Dunn, A. (2000). Variables related to meeting    the 
CDC/ACSM physical activity guidelines. Medicine & Science in Sports & Exercise, 
32(12): 2087-2092. 
 
Sidman, C., Corbin, C., & Le Masurer, G. (2004). Promoting physical activity among sedentary 
women using pedometers. Research Quarterly for Exercise and Sport (Reston, Va.), 
75(2): 122-129. 
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Appendix B 
James Madison University 
Department of Health Sciences 
Health Assessment and Promotion 
Medical History Questionnaire 
 
Name                      DOB      Age    
Address                              Phone   Gender          M          F  
       Height   Weight   
Email:                    Date                 
  
Stage 1 - Known Diseases (Medical Conditions) 
 
1. List the medications you take on a regular basis: 
Medication Purpose Dosage Frequency 
    
    
    
    
 2. Do you have diabetes?        No Yes 
a) If yes, please indicate if it is insulin dependent diabetes mellitus 
    (IDDM) or non-insulin dependent diabetes mellitus (NIDDM).             IDDM  NIDDM 
b) If IDDM, for how many years have you had IDDM?      Years 
3. Have you had a stroke?        No  Yes 
4. Has your doctor ever said you have heart disease?     No  Yes 
5. Do you take asthma medication?       No  Yes 
6. Are you, or do you have reason to believe, you may be pregnant?   No  Yes 
7. Is there any other physical reason that prevents you from participating in an exercise program, 
(e.g., cancer, osteoporosis, severe arthritis, mental illness, thyroid, kidney, or liver 
disease)?         No  Yes 
 
a) If yes, please explain:        
            
 
Stage 2 - Signs and Symptoms 
8. Do you often have pains in your heart, chest, or surrounding areas, especially during exercise? 
           
 No  Yes 
9. Do you often feel faint or have spells of severe dizziness during exercise?    
           
 No  Yes 
10. Do you experience unusual fatigue or shortness of breath at rest or with mild exertion?  
           
 No  Yes 
11. Have you had an attack of shortness of breath that came on after you stopped exercising?  
           
 No  Yes 
12. Have you been awakened at night by an attack of shortness of breath?    
           
 No  Yes 
13. Do you experience swelling or accumulation of fluid in or around your ankles?   
           
 No  Yes 
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14. Do you often get the feeling that your heart is beating faster, racing, or skipping beats, either 
at rest or during exercise?         
 No  Yes 
15. Do you regularly get pains in your calves and lower legs during exercise, which are not due to 
soreness or stiffness?          
 No  Yes 
16. Has your doctor ever told you that you have a heart murmur?   No Yes 
 
Stage 3 - Cardiac Risk Factors 
17. Do you smoke cigarettes on a daily basis, or have you quit smoking within the past two 
years?            
 No   Yes 
If yes, how many cigarettes per day do you smoke (or did you smoke in the past two years)?  
            
  per day 
18. Has your doctor ever told you that you have high blood pressure?   No       Yes 
19. Have any family members or relatives had a heart attack, stroke, or sudden death before the 
age of 65years?        No       Yes 
If yes, 
a) Was the relative male or female?      Male Female 
b) At what age did he or she suffer the stroke or heart attack?     Years 
c) If they died suddenly, what was the cause?         
20. Have you experienced menopause before the age of 45?    No      Yes 
21. If yes, do you take hormone replacement medication?    No      Yes 
 
 Enter blood pressure and blood lipid values:       
  
22. What is your systolic blood pressure?       
 mmHg 
23. What is your diastolic blood pressure?       
 mmHg 
24. What is your serum cholesterol level?    mmol/L  or      mg/dL 
25. What is your serum HDL level?    mmol/L  or      mg/dL  
26. What is your serum triglyceride level?   mmol/L  or      mg/dL 
  
Stage 4 - Exercise Intentions 
 
27. Does your job involve sitting for a large part of the day?    No      Yes 
28. What are your current activity patterns? 
a) Frequency:             exercise sessions per week 
b) Intensity:                   ___Sedentary   ____Moderate   ___Vigorous 
c) History:                 <3 month 3-12 months >12 
months 
d) Duration:                         minutes per session 
29. What types of exercises do you do?        
             
30. Do you want to exercise at a moderate intensity (e.g., brisk walking) or at a vigorous intensity 
(e.g., jogging)?         Moderate     Vigorous 
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31.  List Your Hospitalization History 
 
Age of 
hospitalization 
Reason for Hospitalization Duration 
of Stay 
Comments 
    
    
    
    
    
 
32.  List Any Childhood Diseases 
 
Disease Age 
  
  
  
 
33.  Family history of Heart Disease/Stroke 
Indicate immediate family members (parents, siblings, aunts, uncles) who have diagnosed heart 
disease/stroke and/or who have died from heart disease/stroke. 
 
Relationship Type of  Disease Age at 
Diagnosis 
Age at Death 
    
    
    
    
    
 
34. a.  How many hours do you sleep per night (on average)? ____________    
35. How would you describe the quality of you sleep?   
Good ________ Average ________Poor ______ 
36. a.  Do you consider your day stressful?            Yes _______ No ________ 
37. What is the nature of your stress?          
             
38. How do you handle your stress?         
             
 
39. Do you consider yourself overweight?            Yes _______ No ________ 
40. How long have you been overweight?  ___________________________________________ 
41. How many pounds would you like to lose?        
42. Do you smoke?               Yes _______ No ________ 
43. What do you smoke? _________________________________________________________ 
44. How much do you smoke?__________________ How often?_________________________ 
45. Have you ever smoked in the past?             Yes _______ No ________ 
46. What did you smoke?  _______________________________________________________ 
47. How many years? ___________How much?  ______________  How often?_____________ 
48. When did you stop? __________________________________________________________ 
49. Why did you stop?  __________________________________________________________ 
50. Do you drink alcohol?              Yes _______ No ________ 
51. If yes, what kind? ____________________________________________________________ 
52. How much? _________________________How often? _____________________________ 
53. Have you ever drunk alcohol in the past?            Yes _______ No ________ 
54. If yes, what kind? ____________________________________________________________ 
55. How much? _____________________________ How often? _________________________ 
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56. How many years did you drink?_________________________________________________ 
57. When did you stop? __________________________________________________________ 
58. Why did you stop? ___________________________________________________________ 
59.  Any other pertinent information not covered above      
            
             
I agree that the information is true, accurate, and complete to the best of my knowledge, 
and that I am not withholding any information about my medical or health history that 
would affect my ability to perform physical activities. 
 
Participant Signature: _______________________________ Date: _____________________ 
  
Witness: __________________________________________ Date: ______________________ 
 
 
 
I,     , have reviewed the information contained in this document 
make the following recommendation for exercise testing: 
 This individual is able to perform an exercise stress test without any physician 
supervision. 
 This individual may not perform an exercise stress test unless a physician is within the 
physical premises. 
 This individual may not perform an exercise stress test unless a physician is directly 
supervising the test. 
 
Physician's Signature: _______________________________ Date: __________________ 
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Appendix C 
James Madison University 
Effects of a pedometer based step goal on metabolic indices after 12 weeks 
Department of Health Sciences 
Consent for Investigative Procedure 
(Informed Consent) 
 
Identifications of Investigators & Purpose of Study 
You are being asked to participate in a research study conducted by Valerie 
Lambert, Dr. David Wenos, Dr. Tammy Wagner, Dr. Michael Deaton, and Dr. 
Kent Todd from James Madison University. The purpose of this study is to 
evaluate the utility of pedometers and determine the health benefits from walking 
30 minutes, five days a week for twelve weeks in a sedentary adult population. 
Changes in blood pressure, maximal oxygen uptake (VO2 max), body 
composition, bone mineral density, c-reactive protein, and lipid profiles (total 
cholesterol, high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-
cholesterol (LDL-C), triglycerides, and glucose) will all be measured. A dietary 
assessment will also be assessed at the beginning and end of the study. 
Participants will either exercise on their own or attend a supervised walking 
group 5 days a week for 30 minutes for 12 weeks.  
 
Research Procedures 
Should you decide to participate in this research study, you will be asked to sign 
this consent form once all your questions have been answered to your 
satisfaction. You will be asked to complete a health history questionnaire which 
will be reviewed by Dr. Diduch, M.D. prior to your participation in the study. Your 
involvement in the study will involve an orientation session, pre-test 
measurements, possibility of either a supervised or independent walking program 
lasting 12 weeks, and post-intervention testing. Only those randomly assigned to 
the supervised walking group will be required to meet during the week. All other 
participants will exercise on their own. The orientation session will be held in the 
Human Performance Lab located in the Health and Human Services building 
3009 and will familiarize you with all testing procedures and you will receive a 
three day diet record. Approximately a week later you will return to the Human 
Performance Lab for pre-intervention testing. Height, weight, resting heart rate 
and blood pressure will be taken prior to testing. Lipid profile and c-reactive 
protein (CRP) blood samples will be taken next, followed by the DXA 
measurement and treadmill test.  
 
All blood samples will be collected via fingerstick. Participants will be asked to 
report to the lab hydrated to increase blood flow. The finger will be prepped with 
an alcohol prep pad and pricked using a Tenderlet lancet and a blood sample will 
be collected using a capillary tube. The sample will be dropped into a cassette 
tape and inserted into the Cholestech LDX analyzer. Values for all blood samples 
will be given through a printout.  
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Dual-energy x-ray absorptiometry (DXA) will be used to assess bone mineral 
density as well as estimates of bone, fat, and muscle tissue. A whole body scan 
will be measured at the beginning and conclusion of the study. The importance of 
these measurements is to find excess body fat and/or decreased bone mineral 
density. Each scan will last approximately five minutes. According to the 
manufacture’s specifications, one DXA scan exposes subjects to 1.5 mrem of 
radiation. The exposure to radiation during a single chest x-ray (i.e., 5 mrem) is 
more than 3 times greater than radiation from DXA. Also, the radiation from one 
DXA scan is equivalent to 1.5 days of natural background radiation in the United 
States. 
 
 
The treadmill test follows a predetermined protocol to obtain a maximal oxygen 
uptake. This protocol includes intervals of 2.5% grade that increase every three 
minutes starting at 0% grade. Speed will remain constant throughout the test. 
You will be fitted with a heart rate monitor chest strap and a pulmonary face 
mask. Nonverbal cues will be used to communicate during the test. Hand signals 
include “yes,” “no,” and/or “stop the test.” We may stop the test at any time due to 
signs of fatigue or abnormal physiological responses. These may include failure 
for heart rate to increase with increased workload, dizziness, chest pains, or 
muscular fatigue. This is a volitional exercise test, so it is important to realize that 
you may stop the test when you wish because of feelings of fatigue or any other 
discomfort. Please note that both protocols and procedures are in adherence 
with the guidelines set forth by the American College of Sports Medicine for 
exercise testing. You will be permitted to leave once post exercise heart rate 
drops below 100 beats per minute or resting heart rate level. Avoid a hot shower 
and a heavy meal for at least an hour after the exercise test. 
 
Should you decide to participate in this research study, you will be asked to sign 
this consent form once all your questions have been answered to your 
satisfaction. In addition to the physical health assessment, this study consists of 
demographic information and dietary records that will be administered to 
individual participants in the Human Performance Lab, HHS 3009. 
 
Time Required 
Participation in this study will require approximately 15 weeks. An orientation 
session will require approximately one hour and will include one lap around the 
outdoor track. Pre-intervention testing will require approximately an hour and will 
include height, weight, blood pressure, fingerstick, DXA, and treadmill test. Each 
walking session will last 30 minutes five days a week for 12 weeks. Post-
intervention testing will require approximately an hour and will include height, 
weight, blood pressure, fingerstick, DXA, and treadmill test.  
 
Potential Risks 
The investigator does not perceive more than minimal risks from your 
involvement in this study. The measurements of c-reactive protein, lipids, body 
60 
 
 
composition, bone mineral density, and blood pressure are usual clinical physical 
health assessments, with no overt risks. Although a volitional maximal graded 
exercise test includes a risk for a cardiac incident or possible death, to further 
minimize your risk during exercise testing, Dr. Diduch, M.D. will evaluate your 
written medical and physical activity history, prior to participation. An orientation 
session will be conducted prior to any testing. Exposure to radiation during the 
DXA scan is minimal.  According to the manufacture’s specifications, one DXA 
scan exposes subjects to 1.5 mrem of radiation. The exposure to radiation during 
a single chest x-ray (i.e., 5 mrem) is more than 3 times greater than radiation 
from DXA. Also, the radiation from one DXA scan is equivalent to 1.5 days of 
natural background radiation in the United States 
 
Benefits 
Potential benefits from participation in this study include free testing of 
cardiorespiratory endurance, body composition, bone mineral density, c-reactive 
protein, and lipid profile. The investigators expect to see positive metabolic 
changes for participants that may result in improved health and general well 
being. Participants will also learn about dietary intake and their percentages of 
energy nutrients and total caloric intake. Participation in this study will also help 
investigators understand metabolic responses to long-term exercise and 
potentially provide a tool for accumulating the recommended amount of daily 
exercise.  
 
Confidentiality 
The results of this research will be presented at thesis defense and the American 
College of Sports Medicine, American Dietetics Association, and Southeast 
American College of Sports Medicine Conferences. The results of this project will 
be coded in such a way that the respondent’s identity will not be attached to the 
final form of this study. The researcher retains the right to use and publish non-
identifiable data. While individual responses are confidential, aggregate data will 
be presented representing averages or accessible only to the researcher. Upon 
completion of the study, all information that matches up individual respondents 
with their answers will be destroyed. Final aggregate results will be made 
available to participants upon request.  
 
Participation & Withdrawal 
Your participation is entirely voluntary. You are free to choose not to participate. 
Should you choose to participate, you can withdraw at any time without 
consequences of any kind. 
 
Questions 
You may have questions or concerns during the time of your participation in this 
study, or after its completion. If you have any questions about the study, contact 
Valerie Lambert at lamberva@dukes.jmu.edu or Dr. David Wenos at 
wenosdl@jmu.edu or 540-568-3928. 
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Questions about Your Rights as a Research Subject 
Dr. David Cockley  
Chair, Institutional Review Board 
James Madison University 
(540) 568-2834 
cocklede@jmu.edu 
Giving of Consent 
I have read this consent form and I understand what is being requested of me as 
a participant in this study.  I freely consent to participate.  I have been given 
satisfactory answers to my questions.  The investigator provided me with a copy 
of this form.  I certify that I am at least 18 years of age. 
 
______________________________________     
Name of Participant (Printed) 
 
______________________________________    ______________ 
Name of Participant (Signed)                                   Date 
______________________________________    ______________ 
Name of Researcher (Signed)                                   Date 
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Appendix D 
 
Food Record 
Three Day Food Record Instructions 
 Please keep your record for three days on the forms provided. 
 The days should include two weekdays and one weekend day. 
 Select days that will most closely resemble your eating habits. 
 This record should include all meals, snacks, and beverages including water and 
cocktails.  Anything you put in your mouth should be listed. 
 If possible, weigh and/or measure your food before you eat it. 
 Record what you eat and drink as soon as you can to reduce the chance of 
forgetting.  Be as specific as possible by writing down brand names, food 
preparation methods and anything added to the foods such as condiments, spices 
and other seasonings. 
 Also record the time you consume each food and the meal (i.e. Breakfast, snack 
etc.). 
 Your food intake will be analyzed using the Diet Analysis + 9.0 Online Access. 
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Food Record 
 
Subject Number    Date    Day of Week   
 
Time Meal 
(Breakfast, 
Lunch, 
Supper, 
Snack) 
Brand Name of 
Food Product 
(Lean cuisine, 
Nabisco etc.) 
Food/Drink Quantity Preparation 
(Broil, Bake, 
Fried, Sautee 
etc.) 
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Food Record 
 
Subject Number    Date    Day of Week   
 
Time Meal 
(Breakfast, 
Lunch, 
Supper, 
Snack) 
Brand Name of 
Food Product 
(Lean cuisine, 
Nabisco etc.) 
Food/Drink Quantity Preparation 
(Broil, Bake, 
Fried, Sautee 
etc.) 
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Food Record 
 
Subject Number    Date    Day of Week   
 
Time Meal 
(Breakfast, 
Lunch, 
Supper, 
Snack) 
Brand Name of 
Food Product 
(Lean cuisine, 
Nabisco etc.) 
Food/Drink Quantity Preparation 
(Broil, Bake, 
Fried, Sautee 
etc.) 
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